Drug Loading in Poly(butyl cyanoacrylate)-Based Polymeric Microbubbles.
PBCA
corticosteroids
drug delivery
microbubbles
theranostics
ultrasound
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
03 08 2020
03 08 2020
Historique:
pubmed:
27
6
2020
medline:
29
6
2021
entrez:
27
6
2020
Statut:
ppublish
Résumé
Microbubbles (MB) are routinely used ultrasound (US) contrast agents that have recently attracted increasing attention as stimuli-responsive drug delivery systems. To better understand MB-based drug delivery, we studied the role of drug hydrophobicity and molecular weight on MB loading, shelf-life stability, US properties, and drug release. Eight model drugs, varying in hydrophobicity and molecular weight, were loaded into the shell of poly(butyl cyanoacrylate) (PBCA) MB. In the case of drugs with progesterone as a common structural backbone (i.e., for corticosteroids), loading capacity and drug release correlated well with hydrophobicity and molecular weight. Conversely, when employing drugs with no structural similarity (i.e., four different fluorescent dyes), loading capacity and release did not correlate with hydrophobicity and molecular weight. All model drug-loaded MB formulations could be equally efficiently destroyed upon exposure to US. Together, these findings provide valuable insights on how the physicochemical properties of (model) drug molecules affect their loading and retention in and US-induced release from polymeric MB, thereby facilitating the development of drug-loaded MB formulations for US-triggered drug delivery.
Identifiants
pubmed: 32589435
doi: 10.1021/acs.molpharmaceut.0c00242
pmc: PMC7611892
mid: EMS137156
doi:
Substances chimiques
Fluorescent Dyes
0
Pharmaceutical Preparations
0
Polymers
0
Enbucrilate
F8CEP82QNP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2840-2848Subventions
Organisme : European Research Council
ID : 864121
Pays : International
Références
Ultrasound Med Biol. 2011 Oct;37(10):1622-34
pubmed: 21924206
Curr Med Chem. 2009;16(5):627-42
pubmed: 19199927
Bubble Sci Eng Technol. 2009 Nov;1(1-2):3-17
pubmed: 20574549
J Control Release. 2017 Aug 10;259:128-135
pubmed: 28279799
Int J Pharm. 2011 Jul 29;414(1-2):161-70
pubmed: 21609756
J Control Release. 2012 Oct 10;163(1):75-81
pubmed: 22580225
Int J Cancer. 2007 Aug 15;121(4):901-7
pubmed: 17437269
Nat Rev Drug Discov. 2005 Mar;4(3):255-60
pubmed: 15738980
Curr Pharm Des. 2012;18(15):2135-51
pubmed: 22352769
Future Med Chem. 2018 Dec 6;:
pubmed: 30520324
Macromol Biosci. 2017 Oct;17(10):
pubmed: 28371270
J Control Release. 2019 Jan 28;294:1-16
pubmed: 30527754
Oncotarget. 2017 Jun 27;8(26):42359-42371
pubmed: 28418846
J Control Release. 2010 Nov 20;148(1):13-17
pubmed: 20691227
Contrast Media Mol Imaging. 2011 Jul-Aug;6(4):267-74
pubmed: 21861287
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1193-208
pubmed: 18474406
Nanomedicine. 2009 Dec;5(4):419-23
pubmed: 19523421
Prog Cardiovasc Dis. 2001 Jul-Aug;44(1):45-54
pubmed: 11533926
Biomaterials. 2011 Sep;32(26):6155-63
pubmed: 21632103
Biomed Res Int. 2019 Oct 1;2019:6792465
pubmed: 31662987
Br J Pharmacol. 2006 Jun;148(3):245-54
pubmed: 16604091
Chem Commun (Camb). 2012 May 25;48(42):5142-4
pubmed: 22516972
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1153-66
pubmed: 18486268
Drug Deliv Transl Res. 2012 Feb;2(1):56-64
pubmed: 25786599
Bioconjug Chem. 2005 Jan-Feb;16(1):9-17
pubmed: 15656569
J Nanobiotechnology. 2016 Jan 08;14:1
pubmed: 26743777
Drug Discov Today Technol. 2016 Jun;20:41-48
pubmed: 27986222
Nat Rev Drug Discov. 2004 Jun;3(6):527-32
pubmed: 15173842